Obese individuals with type 2 diabetes should perform resistance exercises after dinner
the ONA take:
According to a new study published in the Journal of Applied Physiology, researchers from the University of Missouri Department of Nutrition and Exercise Physiology have found that individuals with type 2 diabetes can decrease their risk of cardiovascular diseases more effectively by exercising after dinner.
For the study, researchers studied the effects of resistance exercises, such as abdominal crunches, leg curls, and seated calf raises in obese individuals with type 2 diabetes. During one visit, participants exercised for 45 minutes before eating dinner and after dinner during another visit.
Results showed that participants who exercised before dinner were only able to reduce the blood sugar levels, but participants who exercised after dinner were able to reduce both fat and sugar levels. This research may provide insight for those who exercise every day but are not experiencing any weight loss benefit.
The researchers also found that blood sugar and fat level improvements did not extend into the next day, suggesting that individuals need to practice daily resistance exercise after to dinner to maintain these improvements.
Individuals with type 2 diabetes can decrease their risk of cardiovascular diseases more effectively by exercising after dinner.
Sign Up for Free e-newsletters
- New Hypertension Threshold Guides Blood Pressure Management During Cancer Treatment
- Sexual Aids and Resources Not Readily Available at Cancer Centers
- Factors Affecting Employment Participation in Early-stage Breast Cancer
- 5-Year Overall Survival in Endometrial Cancer Not Improved With Chemoradiotherapy
- Gas Mixture Improves Efficacy of Breakthrough Cancer Pain Treatment
- Sitting With Silence in End-of-Life Cancer Care
- Obesity and Cancer Risk (Fact Sheet)
- Susceptibility Gene Mutations Common in Those With Pancreatic Cancer and History of Other Cancers
- Anticancer Properties of Omega-3 Fatty Acids: Plant-Based vs Marine-Based
- US Pharmacopeia Revises Chapter on Handling Hazardous Drugs
- Follow-Up After Treatment Lacking for Younger Cancer Survivors
- Adjuvant Vemurafenib Does Not Improve Disease-Free Survival in Melanoma
- Profile of Buparlisib and its Potential in the Treatment of Breast Cancer: Evidence to Date
- Exercise Before Lung Cancer Surgery Greatly Reduces Complications
- Hodgkin Lymphoma Treatment in EU vs US: Similarities Would Enable Worldwide Studies
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|